Newcastle Firm Appoints Interim CEO After Leadership Probe
Newcastle-based SkinBioTherapeutics has appointed Rachel Parsonage as interim CEO for six months following the resignation of former CEO Stuart Ashman amid an investigation into financial misrepresentation.


